{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:23:08Z","timestamp":1791354188105,"version":"4.3.1"},"reference-count":167,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T00:00:00Z","timestamp":1690675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes.<\/jats:p>","DOI":"10.3390\/life13081663","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T01:28:46Z","timestamp":1690766926000},"page":"1663","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life\u2014A Narrative Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-8051","authenticated-orcid":false,"given":"Viviana","family":"Elian","sequence":"first","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050471 Bucharest, Romania"},{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, \u201cProf. Dr. N. C. Paulescu\u201d National Institute of Diabetes, Nutrition and Metabolic Diseases, 030167 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9696-5728","authenticated-orcid":false,"given":"Violeta","family":"Popovici","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Dental Medicine, Ovidius University of Constanta, 7 Ilarie Voronca Street, 900684 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma-Adriana","family":"Ozon","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-8065","authenticated-orcid":false,"given":"Adina","family":"Musuc","sequence":"additional","affiliation":[{"name":"Romanian Academy, \u201cIlie Murgulescu\u201d Institute of Physical Chemistry, 202 Spl. Independentei, 060021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4705-4204","authenticated-orcid":false,"given":"Ancu\u021ba","family":"Fi\u021ba","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Rusu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050471 Bucharest, Romania"},{"name":"Department of Diabetes, N. Malaxa Clinical Hospital, 12 Vergului Street, 022441 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Radulian","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050471 Bucharest, Romania"},{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, \u201cProf. Dr. N. C. Paulescu\u201d National Institute of Diabetes, Nutrition and Metabolic Diseases, 030167 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumitru","family":"Lupuliasa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,30]]},"reference":[{"key":"ref_1","first-page":"643","article-title":"Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group","volume":"69","author":"King","year":"1991","journal-title":"Bull. World Health Organ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/diabetology2020004","article-title":"Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management","volume":"2","author":"Alam","year":"2021","journal-title":"Diabetology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.117.310221","article-title":"Highlighting Diabetes Mellitus","volume":"38","author":"Schmidt","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrendo.2015.8","article-title":"Combination immunotherapies for type 1 diabetes mellitus","volume":"11","author":"Pozzilli","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11892-017-0878-z","article-title":"Combination Immunotherapy for Type 1 Diabetes","volume":"17","author":"Bone","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"730414","DOI":"10.3389\/fimmu.2021.730414","article-title":"Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes","volume":"12","author":"Thomas","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00125-021-05398-3","article-title":"Current and future therapies for type 1 diabetes","volume":"64","author":"Kreiner","year":"2021","journal-title":"Diabetologia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/immunohorizons.2000105","article-title":"Timing of Immunotherapy in Type 1 Diabetes: The Earlier, the Better?","volume":"5","author":"Felton","year":"2021","journal-title":"Immunohorizons"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00005-020-00578-2","article-title":"Crosstalk Between Immunity System Cells and Pancreas. Transformation of Stem Cells Used in the 3D Bioprinting Process as a Personalized Treatment Method for Type 1 Diabetes","volume":"68","author":"Cywoniuk","year":"2020","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eabc8980","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_12","first-page":"486","article-title":"Prevention of type 1 diabetes: Where we are and where we are going","volume":"73","author":"Frontino","year":"2021","journal-title":"Minerva Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00125-018-4786-9","article-title":"Treatment of type 1 diabetes with teplizumab: Clinical and immunological follow-up after 7 years from diagnosis","volume":"62","author":"Perdigoto","year":"2019","journal-title":"Diabetologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103493","DOI":"10.1016\/j.etap.2020.103493","article-title":"Review: Usnic acid-induced hepatotoxicity and cell death","volume":"80","author":"Kwong","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00125-004-1365-z","article-title":"Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes","volume":"47","author":"Hermansen","year":"2004","journal-title":"Diabetologia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2337\/dc15-0801","article-title":"Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection","volume":"38","author":"Lucidi","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jpc.14480","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes","volume":"55","author":"Ross","year":"2019","journal-title":"J. Paediatr. Child Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11255-015-1175-x","article-title":"The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease","volume":"48","author":"Savu","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"ref_19","first-page":"1177","article-title":"The Rising Cost of Insulin for Pump Users: How Policy Drives Prices","volume":"15","author":"Chhabra","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/dme.12879","article-title":"Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial","volume":"33","author":"Lawton","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamainternmed.2018.5008","article-title":"Cost-Related Insulin Underuse among Patients with Diabetes","volume":"179","author":"Herkert","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Moro\u0219an, E., Popovici, V., Elian, V., D\u0103r\u0103ban, A.M., Rusu, A.I., Licu, M., Mititelu, M., and Karampelas, O. (2023). The Impact of Medical Nutrition Intervention on the Management of Hyperphosphatemia in Hemodialysis Patients with Stage 5 Chronic Kidney Disease: A Case Series. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20065049"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Stankute, I., Radzeviciene, L., Monstaviciene, A., Dobrovolskiene, R., Danyte, E., and Verkauskiene, R. (2022). Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients. Medicina, 58.","DOI":"10.3390\/medicina58020218"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17950","DOI":"10.1038\/s41598-022-22932-4","article-title":"The significance of chronic kidney disease, heart failure and cardiovascular disease for mortality in type 1 diabetes: Nationwide observational study","volume":"12","author":"Eliasson","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4158\/EP.12.S1.34","article-title":"Insights from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes","volume":"12","author":"Genuth","year":"2006","journal-title":"Endocr. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2251-6581-11-28","article-title":"Diabetes and tuberculosis: A review of the role of optimal glycemic control","volume":"11","author":"Niazi","year":"2012","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3855\/jidc.15797","article-title":"Vulnerable territories to tuberculosis-diabetes mellitus comorbidity in a northeastern Brazilian scenario","volume":"16","author":"Yamamura","year":"2022","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000488670","article-title":"Interplay between type 1 diabetes mellitus and celiac disease: Implications in treatment","volume":"36","author":"Kaur","year":"2018","journal-title":"Dig. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3476(72)80300-7","article-title":"Addison\u2019s disease and diabetes mellitus","volume":"81","author":"Kogut","year":"1972","journal-title":"J. Pediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"A624","DOI":"10.1210\/jendso\/bvac150.1295","article-title":"PMON315 Hyperglycemia Dilemma: Concomitant Type 1 Diabetes Mellitus and Cushing\u2019s disease","volume":"6","author":"Ingley","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"ref_31","first-page":"261","article-title":"The multifarious cushing\u2019s\u2013Lessons from a case series","volume":"15","author":"Ilie","year":"2019","journal-title":"Acta Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/dia.2019.0228","article-title":"The Choice Should Be Yours: Diabetes-Related Distress by Insulin Delivery Method for People with Type 1 Diabetes","volume":"22","author":"Wardian","year":"2020","journal-title":"Diabetes Technol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.21037\/tp.2017.10.04","article-title":"Psychosocial aspects of diabetes management: Dilemma of diabetes distress","volume":"6","author":"Tareen","year":"2017","journal-title":"Transl. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/1932296816645365","article-title":"Impact of Type 1 Diabetes Technology on Family Members\/Significant Others of People with Diabetes","volume":"10","author":"Barnard","year":"2016","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.mpmed.2022.08.011","article-title":"Psychological aspects of diabetes management","volume":"50","author":"Davies","year":"2022","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mianowska, B., Fedorczak, A., Michalak, A., Pokora, W., Bara\u0144ska-Nowicka, I., Wilczy\u0144ska, M., and Szadkowska, A. (2021). Diabetes related distress in children with type 1 diabetes before and during the covid-19 lockdown in spring 2020. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168527"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/jocn.15742","article-title":"Factors associated with diabetes distress among adolescents with type 1 diabetes","volume":"30","author":"Luo","year":"2021","journal-title":"J. Clin. Nurs."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Schmidt, C.B., Voorhorst, I., Van De Gaar, V.H.W., Keukens, A., Potter Van Loon, B.J., Snoek, F.J., and Honig, A. (2019). Diabetes distress is associated with adverse pregnancy outcomes in women with gestational diabetes: A prospective cohort study. BMC Pregnancy Childbirth, 19.","DOI":"10.1186\/s12884-019-2376-6"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/dme.14157","article-title":"Twenty-five years of diabetes distress research","volume":"37","author":"Skinner","year":"2020","journal-title":"Diabet. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e056304","DOI":"10.1136\/bmjopen-2021-056304","article-title":"How to identify clinically significant diabetes distress using the Problem Areas in Diabetes (PAID) scale in adults with diabetes treated in primary or secondary care? Evidence for new cut points based on latent class analyses","volume":"12","author":"Pouwer","year":"2022","journal-title":"BMJ Open"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diacare.28.3.626","article-title":"Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dia.2011.0162","article-title":"Health-related quality of life and treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial","volume":"14","author":"Rubin","year":"2012","journal-title":"Diabetes Technol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5603\/DK.2017.0018","article-title":"New technologies and metabolic control in type 1 diabetes mellitus","volume":"6","author":"Klamann","year":"2017","journal-title":"Clin. Diabetol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kimbell, B., Lawton, J., Boughton, C., Hovorka, R., and Rankin, D. (2021). Parents\u2019 experiences of caring for a young child with type 1 diabetes: A systematic review and synthesis of qualitative evidence. BMC Pediatr., 21.","DOI":"10.1186\/s12887-021-02569-4"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/MDER.S312858","article-title":"Barriers to uptake of insulin technologies and novel solutions","volume":"14","author":"Pauley","year":"2021","journal-title":"Med. Devices Evid. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13643-020-01373-y","article-title":"Cost-effectiveness of health technologies in adults with type 1 diabetes: A systematic review and narrative synthesis","volume":"9","author":"Pease","year":"2020","journal-title":"Syst. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/dme.13588","article-title":"Diabetes technology: Improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes","volume":"35","author":"Prahalad","year":"2018","journal-title":"Diabet. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1037\/a0040383","article-title":"Psychology, technology, and diabetes management","volume":"71","author":"Shepard","year":"2016","journal-title":"Am. Psychol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diabres.2005.05.013","article-title":"A comparison of blood glucose meters in Australia","volume":"71","author":"Cohen","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_50","first-page":"379","article-title":"Application of health informatics in the education of diabetic patients for the improvement of self-management and reporting to specialists","volume":"5","author":"Apostolopoulos","year":"2007","journal-title":"J. Inf. Technol. Healthc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/dci18-0002","article-title":"Diabetes technology update: Use of insulin pumps and continuous glucose monitoring in the hospital","volume":"41","author":"Umpierrez","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-021-01375-7","article-title":"Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: To Wear or Not to Wear","volume":"21","author":"Yeh","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dsx.2017.09.005","article-title":"A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus","volume":"12","author":"Olczuk","year":"2018","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"660173","DOI":"10.3389\/fped.2021.660173","article-title":"Intermittently Scanned and Continuous Glucose Monitor Systems: A Systematic Review on Psychological Outcomes in Pediatric Patients","volume":"9","author":"Franceschi","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0140-6736(21)00789-3","article-title":"Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): A 6-month, prospective, multicentre, randomised controlled trial","volume":"397","author":"Visser","year":"2021","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., and Sparacino, G. (2017). Wearable continuous glucose monitoring sensors: A revolution in diabetes treatment. Electron., 6.","DOI":"10.3390\/electronics6030065"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zafar, H., Channa, A., Jeoti, V., and Stojanovi\u0107, G.M. (2022). Comprehensive Review on Wearable Sweat-Glucose Sensors for Continuous Glucose Monitoring. Sensors, 22.","DOI":"10.3390\/s22020638"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Staal, O.M., Hansen, H.M.U., Christiansen, S.C., Fougner, A.L., Carlsen, S.M., and Stavdahl, \u00d8. (2018). Differences between flash glucose monitor and fingerprick measurements. Biosensors, 8.","DOI":"10.3390\/bios8040093"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e001193","DOI":"10.1136\/bmjdrc-2020-001193","article-title":"Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus","volume":"8","author":"Fokkert","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1039\/D1SD00030F","article-title":"Recent advances in optical sensors for continuous glucose monitoring","volume":"1","author":"Ahmed","year":"2022","journal-title":"Sens. Diagn."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/biostatistics\/kxaa023","article-title":"Modeling continuous glucose monitoring (CGM) data during sleep","volume":"23","author":"Gaynanova","year":"2022","journal-title":"Biostatistics"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Urakami, T. (2023). The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes. J. Clin. Med., 12.","DOI":"10.3390\/jcm12030781"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1089\/dia.2015.0345","article-title":"Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects","volume":"18","author":"Kropff","year":"2016","journal-title":"Diabetes Technol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/193229681300700408","article-title":"Susceptibility of interstitial continuous glucose monitor performance to sleeping position","volume":"7","author":"Mensh","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_65","first-page":"A62","article-title":"Multiday outpatient glycemic control in adolescents with type 1 diabetes using a bihormonal bionic pancreas: The barton center summer camp study","volume":"63","author":"Russell","year":"2014","journal-title":"Diabetes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/1932296816688303","article-title":"Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?","volume":"11","author":"Shapiro","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections","volume":"167","author":"Beck","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Vettoretti, M., Cappon, G., Facchinetti, A., and Sparacino, G. (2020). Advanced diabetes management using artificial intelligence and continuous glucose monitoring sensors. Sensors, 20.","DOI":"10.3390\/s20143870"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fendo.2018.00818","article-title":"The benefits and limits of technological advances in glucose management around physical activity in patients type 1 diabetes","volume":"10","author":"Tagougui","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_70","first-page":"61","article-title":"Recommendations for Diabetes-Treatment with Systems for Automated Insulin Delivery","volume":"17","author":"Biester","year":"2022","journal-title":"Diabetol. Und Stoffwechs."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wu, P.T., Segovia, D.E., Lee, C.C., and Nguyen, K.L. (2018). Consistency of continuous ambulatory interstitial glucose monitoring sensors. Biosensors, 8.","DOI":"10.3390\/bios8020049"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/193229681100500318","article-title":"Biomechanics of the sensor-tissue interface-Effects of motion, pressure, and design on sensor performance and foreign body response-Part II: Examples and application","volume":"5","author":"Helton","year":"2011","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/dia.2009.0123","article-title":"The effect of body fat, aging, and diabetes on vertical and shear pressure in and under a waist belt and its effect on skin blood flow","volume":"12","author":"Petrofsky","year":"2010","journal-title":"Diabetes Technol. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.ijo.0802541","article-title":"Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall","volume":"28","author":"Ardilouze","year":"2004","journal-title":"Int. J. Obes."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1089\/dia.2009.0002","article-title":"A tale of two compartments: Interstitial versus blood glucose monitoring","volume":"11","author":"Cengiz","year":"2009","journal-title":"Diabetes Technol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2337\/dc06-1602","article-title":"Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System","volume":"30","author":"Weinstein","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1177\/193229681300700511","article-title":"Continuous glucose monitoring in the subcutaneous tissue over a 14-day sensor wear period","volume":"7","author":"Hoss","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/08860220903491232","article-title":"Relationship between insulin resistance and inflammation markers in hemodialysis patients","volume":"32","author":"Borazan","year":"2010","journal-title":"Ren. Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1097-4636(200101)54:1<69::AID-JBM8>3.0.CO;2-Q","article-title":"Influence of inflammatory cells and serum on the performance of implantable glucose sensors","volume":"54","author":"Gerritsen","year":"2001","journal-title":"J. Biomed. Mater. Res."},{"key":"ref_80","first-page":"259","article-title":"Long-term stability of electroenzymatic glucose sensors implanted in mice. An update","volume":"34","author":"Clark","year":"1988","journal-title":"ASAIO Trans."},{"key":"ref_81","first-page":"1","article-title":"Antimicrobial activity of ethanolic extract of Usnea longissima","volume":"2","author":"Thippeswamy","year":"2011","journal-title":"J. Exp. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2710.2009.01048.x","article-title":"Insulin pumps: From inception to the present and toward the future","volume":"35","author":"Alsaleh","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12020-016-1039-x","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: A systematic review and meta-analysis","volume":"55","author":"Benkhadra","year":"2017","journal-title":"Endocrine"},{"key":"ref_84","unstructured":"(2023, March 05). Pros and Cons of Insulin Pumps. Available online: https:\/\/www.diabetes.co.uk\/insulin-pumps."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zeidan, T., Nikkel, C., Dziengelewski, B., Wu, S., and Chen, A.M.H. (2020). Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go\u00ae Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis. Pharmacy, 8.","DOI":"10.3390\/pharmacy8040215"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"109858","DOI":"10.1016\/j.diabres.2022.109858","article-title":"Diabetes Research and Clinical Practice Patch Pumps: What are the advantages for people with diabetes ?","volume":"187","author":"Kulzer","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1932296818814541","article-title":"Insulin Pumping Patches: Emerging Insulin Delivery Systems","volume":"13","author":"Thompson","year":"2019","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/ds18-0091","article-title":"A clinical overview of insulin pump therapy for the management of diabetes: Past, present, and future of intensive therapy","volume":"32","author":"Berget","year":"2019","journal-title":"Diabetes Spectr."},{"key":"ref_89","first-page":"1","article-title":"Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm Real-Time System","volume":"105","author":"Pohar","year":"2007","journal-title":"Issues Emerg. Health Technol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/dia.2011.0084","article-title":"Prevention of Hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy","volume":"13","author":"Danne","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1303576","article-title":"Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/dc17-1604","article-title":"Reduction in Hypoglycemia with the predictive low-Glucose management system: A long-term randomized controlled trial in adolescents with type 1 diabetes","volume":"41","author":"Abraham","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive low-glucose suspend reduces Hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: Results of the PROLOG trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","article-title":"New closed-loop insulin systems","volume":"64","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Chen, C., Zhao, X.L., Li, Z.H., Zhu, Z.G., Qian, S.H., and Flewitt, A.J. (2017). Current and emerging technology for continuous glucose monitoring. Sensors, 17.","DOI":"10.3390\/s17010182"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/a2010518","article-title":"A review of closed-loop algorithms for glycemic control in the treatment of type 1 diabetes","volume":"2","author":"Castle","year":"2009","journal-title":"Algorithms"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.arcontrol.2019.07.004","article-title":"The evolution of control algorithms in artificial pancreas: A historical perspective","volume":"48","author":"Quiroz","year":"2019","journal-title":"Annu. Rev. Control"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4158\/EP-2017-0234","article-title":"Improved HBA1C, total daily insulin dose, and treatment satisfaction with insulin pump therapy compared to multiple daily insulin injections in patients with type 2 diabetes irrespective of baseline C-peptide levels","volume":"24","author":"Vigersky","year":"2018","journal-title":"Endocr. Pract."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jprocont.2020.06.009","article-title":"Artificial pancreas under stable pulsatile MPC: Improving the closed-loop performance","volume":"92","author":"Abuin","year":"2020","journal-title":"J. Process Control"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.conengprac.2018.05.006","article-title":"Model predictive control with integral action for artificial pancreas","volume":"77","author":"Incremona","year":"2018","journal-title":"Control Eng. Pract."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14341\/DM8265","article-title":"Development and in silico validation of the pid-algorithm for the artificial pancreas with intraperitoneal insulin delivery","volume":"21","author":"Karpelyev","year":"2018","journal-title":"Diabetes Mellit."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jprocont.2019.01.002","article-title":"A new animal model of insulin-glucose dynamics in the intraperitoneal space enhances closed-loop control performance","volume":"76","author":"Chakrabarty","year":"2019","journal-title":"J. Process Control"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbe.2018.02.009","article-title":"In silico testing of optimized Fuzzy P+D controller for artificial pancreas","volume":"38","author":"Soylu","year":"2018","journal-title":"Biocybern. Biomed. Eng."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Mehmood, S., Ahmad, I., Arif, H., Ammara, U.E., and Majeed, A. (2020). Artificial pancreas control strategies used for type 1 diabetes control and treatment: A comprehensive analysis. Appl. Syst. Innov., 3.","DOI":"10.3390\/asi3030031"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nyas.12431","article-title":"The artificial pancreas: Current status and future prospects in the management of diabetes","volume":"1311","author":"Peyser","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13300-021-01160-5","article-title":"Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe","volume":"12","author":"Janez","year":"2021","journal-title":"Diabetes Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1932296816668876","article-title":"Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against Hypoglycemia","volume":"11","author":"Dart","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_108","unstructured":"(2023, March 14). Hybrid Closed-Loop Insulin Delivery Systems for People with Type 1 Diabetes. Available online: https:\/\/www.cadth.ca\/hybrid-closed-loop-insulin-delivery-systems-people-type-1-diabetes."},{"key":"ref_109","first-page":"369","article-title":"Home use of a bihormonal bionic pancreas vs. Conventional insulin pump therapy in adults with type 1 diabetes: A multicenter, randomized clinical trial","volume":"65","author":"Elkhatib","year":"2016","journal-title":"Diabetes"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/jc.2013-4151","article-title":"Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes","volume":"99","author":"Russell","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.2337\/dc21-0416","article-title":"The bihormonal bionic pancreas improves glycemic control in individuals with hyperinsulinism and post pancreatectomy diabetes: A pilot study","volume":"44","author":"Rayannavar","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/dia.2022.0167","article-title":"A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes","volume":"24","author":"Beck","year":"2022","journal-title":"Diabetes Technol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.4285\/ATW2021.OP-1183","article-title":"Bionic pancreas: The first results of functionality bionic tissue model with pancreatic islets","volume":"35","author":"Wszola","year":"2021","journal-title":"Korean J. Transplant."},{"key":"ref_114","first-page":"S97","article-title":"Home use of the iLet bionic pancreas in the bihormonal configuration using dasiglucagon versus the insulin-only configuration in adults with type 1 diabetes","volume":"22","author":"Russell","year":"2020","journal-title":"Diabetes Technol. Ther."},{"key":"ref_115","unstructured":"(2023, February 10). NCT03565666. The Insulin-Only Bionic Pancreas Bridging Study, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03565666."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11892-018-1078-1","article-title":"Biopsychosocial Factors Associated with Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: A Call to the Technology Field","volume":"18","author":"Forlenza","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1932296818761457","article-title":"Decision Support in Diabetes Care: The Challenge of Supporting Patients in Their Daily Living Using a Mobile Glucose Predictor","volume":"12","author":"Rigla","year":"2018","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Tyler, N.S., and Jacobs, P.G. (2020). Artificial intelligence in decision support systems for type 1 diabetes. Sensors, 20.","DOI":"10.3390\/s20113214"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jdiacomp.2015.01.012","article-title":"Understanding the sources of diabetes distress in adults with type 1 diabetes","volume":"29","author":"Fisher","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/dia.2014.0417","article-title":"Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life","volume":"17","author":"Polonsky","year":"2015","journal-title":"Diabetes Technol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/dia.2015.0140","article-title":"Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes","volume":"17","author":"Polonsky","year":"2015","journal-title":"Diabetes Technol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2147\/PPA.S142204","article-title":"The effect of peer support in adults with insulin pump-treated type 1 diabetes: A pilot study of a flexible and participatory intervention","volume":"11","author":"Joensen","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"109605","DOI":"10.1016\/j.diabres.2022.109605","article-title":"IDF21-0043 Technology Trio: Continuous Glucose Monitoring, Telehealth, and Electronic Messaging for Insulin-Treated Patients","volume":"186","author":"Rizvi","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_124","first-page":"A225","article-title":"A model of efficiency on introducing technology in T1DM management process for patients with 30+year\u2019s duration of diabetes-a single-center interventional study","volume":"22","author":"Elian","year":"2020","journal-title":"Diabetes Technol. Ther."},{"key":"ref_125","first-page":"e110111","article-title":"The impact of new continuous glucose monitoring (CGM) devices versus self-management of blood glucose (SMBG) on the daily life of parents and children affected by type 1 diabetes mellitus","volume":"11","author":"Fanzola","year":"2022","journal-title":"J. Pediatr. Neonatal Individ. Med."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Rusak, E., Ogarek, N., Wolicka, K., Mr\u00f3wka, A., Seget, S., Ku\u017anik, M., and Jarosz-Chobot, P. (2021). The quality of life and satisfaction with continuous glucose monitoring therapy in children under 7 years of age with T1D using the rTCGM system integrated with insulin pump\u2014A caregivers point of view. Sensors, 21.","DOI":"10.3390\/s21113683"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc17-0133","article-title":"The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: Further findings from the DIAMOND randomized clinical trial","volume":"40","author":"Polonsky","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.2337\/dc08-0720","article-title":"Barriers to physical activity among patients with type 1 diabetes","volume":"31","author":"Brazeau","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00592-023-02070-7","article-title":"Physical exercise and glycemic management in patients with type 1 diabetes on insulin pump therapy\u2014A cross-sectional study","volume":"60","author":"Ferreira","year":"2023","journal-title":"Acta Diabetol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fendo.2019.00326","article-title":"Exercise management for young people with type 1 diabetes: A structured approach to the exercise consultation","volume":"10","author":"Chetty","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/1932296816640289","article-title":"Psychosocial Impact of the Bionic Pancreas during Summer Camp","volume":"10","author":"Hessler","year":"2016","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_132","first-page":"99","article-title":"Factors associated to adherence to blood glucose self-monitoring in patients with diabetes treated with insulin. The dapa study","volume":"65","year":"2018","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_133","first-page":"642","article-title":"Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study","volume":"68","author":"Conde","year":"2021","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/apa.14931","article-title":"Adherence to insulin pump treatment declines with increasing age in adolescents with type 1 diabetes mellitus","volume":"109","author":"Spaans","year":"2020","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1932296816676280","article-title":"Continuous Glucose Monitoring (CGM) Adherence in Youth with Type 1 Diabetes: Associations with Biomedical and Psychosocial Variables","volume":"11","author":"Giani","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Trandafir, L.M., Moisa, S.M., Vlaiculescu, M.V., Butnariu, L.I., Boca, L.O., Constantin, M.M.L., Lupu, P.M., Brinza, C., Temneanu, O.R., and Burlacu, A. (2022). Insulin Pump Therapy Efficacy and Key Factors Influencing Adherence in Pediatric Population-A Narrative Review. Medicina, 58.","DOI":"10.3390\/medicina58111671"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/1932296816638109","article-title":"Psychological Reactions Associated with Continuous Glucose Monitoring in Youth","volume":"10","author":"Patton","year":"2016","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/dia.2011.0201","article-title":"Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth","volume":"14","author":"Markowitz","year":"2012","journal-title":"Diabetes Technol. Ther."},{"key":"ref_139","first-page":"S18","article-title":"TR Parental sleep quality and continuous glucose monitoring system use in children with type 1 diabetes","volume":"17","author":"Landau","year":"2015","journal-title":"Diabetes Technol. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1932296816633484","article-title":"Continuous Glucose Monitoring Adherence: Lessons from a Clinical Trial to Predict Outpatient Behavior","volume":"10","author":"Cooper","year":"2016","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/1932296816688010","article-title":"Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use","volume":"11","author":"Tanenbaum","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/dia.2018.0079","article-title":"Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus","volume":"20","author":"Breton","year":"2018","journal-title":"Diabetes Technol. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dc18-0228","article-title":"Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors","volume":"41","author":"Castle","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2042018819839298","DOI":"10.1177\/2042018819839298","article-title":"Use of apps for physical activity in type 1 diabetes: Current status and requirements for future development","volume":"10","author":"Kordonouri","year":"2019","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcjd.2016.09.007","article-title":"Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24 \u00d7 1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm","volume":"41","author":"Assaloni","year":"2017","journal-title":"Can. J. Diabetes"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Wang, M., Wang, C., Ren, S., Pan, J., Wang, Y., Shen, Y., Zeng, Z., Cui, H., and Zhao, X. (2022). Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063362"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2105619","DOI":"10.1002\/advs.202105619","article-title":"Engineering a Rapid Insulin Release System Controlled by Oral Drug Administration","volume":"9","author":"Mahameed","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-L\u00f3pez, A.L., Carvajal-Millan, E., Canett-Romero, R., Prakash, S., Rasc\u00f3n-Chu, A., L\u00f3pez-Franco, Y.L., Lizardi-Mendoza, J., and Micard, V. (2022). Arabinoxylans-Based Oral Insulin Delivery System Targeting the Colon: Simulation in a Human Intestinal Microbial Ecosystem and Evaluation in Diabetic Rats. Pharmaceuticals, 15.","DOI":"10.3390\/ph15091062"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Liu, G., He, S., Ding, Y., Chen, C., Cai, Q., and Zhou, W. (2022). Multivesicular liposomes for glucose-responsive insulin delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010021"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"103141","DOI":"10.1016\/j.jddst.2022.103141","article-title":"B12-functionalized PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies","volume":"69","author":"Sarhadi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Bahman, F., Taurin, S., Altayeb, D., Taha, S., Bakhiet, M., and Greish, K. (2020). Oral insulin delivery using poly (Styrene co-Maleic acid) micelles in a diabetic mouse model. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111026"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","article-title":"Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions","volume":"15","author":"Han","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2100493","DOI":"10.1002\/mabi.202100493","article-title":"Hyaluronic-Acid-Coated Chitosan Nanoparticles for Insulin Oral Delivery: Fabrication, Characterization, and Hypoglycemic Ability","volume":"22","author":"Wu","year":"2022","journal-title":"Macromol. Biosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2021.11.020","article-title":"Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles","volume":"341","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1248\/bpb.b20-00737","article-title":"In vitro and in vivo comparative study of oral nanoparticles and gut iontophoresis as oral delivery systems for insulin","volume":"44","author":"Elkhatib","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/1061186X.2017.1300664","article-title":"Intestinal micropatches for oral insulin delivery","volume":"25","author":"Banerjee","year":"2017","journal-title":"J. Drug Target."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"268","DOI":"10.32598\/ppj.24.4.70","article-title":"Long-term administration of intranasal insulin improves peripheral glucose concentration in diabetic male rats","volume":"24","author":"Torabi","year":"2020","journal-title":"Physiol. Pharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12630-021-01969-5","article-title":"Intranasal administration of 40 and 80 units of insulin does not cause hypoglycemia during cardiac surgery: A randomized controlled trial","volume":"68","author":"Roque","year":"2021","journal-title":"Can. J. Anesth."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/1673-5374.314320","article-title":"Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice","volume":"17","author":"Zhu","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2018.03.011","article-title":"Insulin delivery systems combined with microneedle technology","volume":"127","author":"Jin","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1021\/acsapm.0c00341","article-title":"Temperature-Stable Boronate Gel-Based Microneedle Technology for Self-Regulated Insulin Delivery","volume":"2","author":"Chen","year":"2020","journal-title":"ACS Appl. Polym. Mater."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1248\/bpb.28.2279","article-title":"Sublingual delivery of insulin: Effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in Vivo hypoglycemic activity","volume":"28","author":"Cui","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijbiomac.2022.02.030","article-title":"In vitro and in vivo evaluation of 3D printed sodium alginate\/polyethylene glycol scaffolds for sublingual delivery of insulin: Preparation, characterization, and pharmacokinetics","volume":"204","author":"Erzengin","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/acsnano.9b06395","article-title":"Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery","volume":"14","author":"Volpatti","year":"2020","journal-title":"ACS Nano"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.msec.2018.11.032","article-title":"Engineering synthetic artificial pancreas using chitosan hydrogels integrated with glucose-responsive microspheres for insulin delivery","volume":"96","author":"Yin","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0963689718809918","article-title":"Bioartificial Organ Manufacturing Technologies","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant."},{"key":"ref_167","first-page":"256","article-title":"Three-dimensional bioprinting of functional \u03b2-islet-like constructs","volume":"9","author":"Parvaneh","year":"2022","journal-title":"Int. J. Bioprinting"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/8\/1663\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:22:43Z","timestamp":1760127763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/8\/1663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,30]]},"references-count":167,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["life13081663"],"URL":"https:\/\/doi.org\/10.3390\/life13081663","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,30]]}}}